Results 91 to 100 of about 30,843 (290)

Dronabinol for chemotherapy-induced nausea and vomiting unresponsive to antiemetics

Cancer Management and Research, 2016
Megan Brafford May,1 Ashley E Glode2 1Department of Pharmacy, Baptist Health Lexington, Lexington, KY, USA; 2Department of Clinical Pharmacy, Skaggs School of Pharmacy and Pharmaceutical Sciences, University of Colorado Anschutz Medical Campus ...
May MB, Glode AE
doaj  

Retrospective analysis of real‐world prescribing data for managing cisplatin‐based chemotherapy‐induced nausea and vomiting in China

Cancer Medicine
Background The current utilization of neurokinin‐1 receptor antagonists (NK1RAs) and the impact of updated guidelines on prescription patterns of antiemetic drugs among Chinese patients receiving highly emetogenic chemotherapy (HEC) remain undetermined ...
Xia Si, Hongyan Zhang, Qingming Ding, Gang Liu, Lin Huang, Xin Sun   +5 more
doaj   +1 more source

The therapeutic aspects of the endocannabinoid system (ECS) for cancer and their development: from nature to laboratory [PDF]

, 2016
The endocannabinoid system (ECS) is a group of neuromodulatory lipids and their receptors, which are widely distributed in mammalian tissues. ECS regulates various cardiovascular, nervous, and immune system functions inside cells.
Botta, Bruno, Czarnecka, Anna M., Khan, Mohammed I., Król, Magdalena, Sobocińska, Anna A., Szczylik, Cezary   +5 more
core   +1 more source

Gall bladder rupture and atrophy causing a hepato‐cutaneous fistula in a dog

Veterinary Record Case Reports, EarlyView.
Abstract An 8‐year‐10‐month‐old, male, neutered Hungarian Vizsla presented with an unresolved discharging nodule on the right aspect of the xiphoid process. The dog was reported to experience intermittent lethargy and inappetence 15 months after 7 days of critical care hospitalisation for significant gastrointestinal clinical signs including ...
Renato Miloro, Barbora Mala, Rachel Garty, Dylan Yaffy, Michal Vlasin   +4 more
wiley   +1 more source

PROPHYLACTIC ANTIEMETIC THERAPY WITH ONDANSETRON, DEXAMETHASONE AND COMBINED ONDANSETRON AND DEXAMETHASONE IN PATIENTS UNDERGOING LAPAROSCOPIC CHOLECYSTECTOMY UNDER GENERAL ANAESTHESIA (GA)

Journal of University Medical & Dental College, 2017
: OBJECTIVE: The aim of this study was to find a better prophylaxis against postoperative nausea and vomiting (PONV) in patients undergoing laparoscopic cholecystectomy. STUDY DESIGN: A randomized control study was carried out for comparison.
Nadia Bano, Nazim Hayat, A.G Rehan
doaj  

A retrospective review of treatment patterns of antiemetic agents for chemotherapy-induced nausea and vomiting

SAGE Open Medicine, 2018
Objectives: To evaluate the treatment pattern of antiemetic agents used for chemotherapy-induced nausea and vomiting in a tertiary hospital in Saudi Arabia. Methods: Over a period of 7 weeks, all new chemotherapy order sheets were collected and evaluated
Abdulrahman Alamri, Yousef A Alawlah, Yanru Qiao, Junling Wang   +3 more
doaj   +1 more source

Study on the antiemetic property of methanolic stem extract of Swertia chirata using chick emesis model [PDF]

, 2019
Background: Swertia chirata has been an important herb known for centuries for its various medicinal uses and bitter taste. The stem of the plant is used as a traditional medicine in an array of diseases including the treatment of vomiting.
Gohain, Kalpana, Medhi, Pranjal Kr.
core   +2 more sources

The epidemiology and phenomenology of non-antipsychotic-induced dystonia: a hybrid systematic-narrative review

European Psychiatry
Background Medication-induced dystonia (MID) is a movement disorder (MD), characterized by involuntary sustained or intermittent muscle contractions, causing abnormal, often repetitive, movements, postures, or both.
Kirsten Catthoor, Johan Detraux, Marc De Hert   +2 more
doaj   +1 more source

Targeting tachykinin receptors in neuroblastoma [PDF]

, 2016
Neuroblastoma is the most common extracranial tumor in children. Despite aggressive multimodal treatment, high-risk neuroblastoma remains a clinical challenge with survival rates below 50%.
Althoff, Kristina, Astrahanseff, Kathy, Beckers, Anneleen, Bergmann, Andreas, De Preter, Katleen, Eggert, Angelika, Henssen, Anton G, Odersky, Andrea, Schramm, Alexander, Schulte, Johannes H, Schäfers, Simon, Seiler, Marleen, Speleman, Franki, Struck, Joachim, Szymansky, Annabell   +14 more
core   +3 more sources

Comparison of the analgesic dose of intravenous ketamine versus ketorolac in patients with chest trauma: A randomized double‐blind clinical trial

Academic Emergency Medicine, EarlyView.
Abstract Background Pain management is a critical part of treatment in patients with chest trauma. Opioids and nonsteroidal anti‐inflammatory drugs have been the most commonly used medications. However, their side effects have drawn attention to other medications.
Hossein Zabihi Mahmoodabadi, Zeynab Seyed Javadein, Fatemeh Moosaie, Ali Faegh, Maryam Bahreini   +4 more
wiley   +1 more source